Epidermal growth factor receptor inhibition alleviates cardiac ischemia/reperfusion injury through preventing mitochondrial dysfunction and ferroptosis via Rho Family GTPase 3/5′ AMP-activated protein kinase axis
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2027
DOI: 10.1016/j.bbadis.2026.168501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2027. Verfasst von Tie Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China; …. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Ferroptosis, ErbB Receptors, AMP-Activated Protein Kinases. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Previous studies have found that the underlying mechanisms of myocardial ischemia/reperfusion injury (MIRI) are complex and involve various regulated cell death including ferroptosis. The focus of this study was to elucidate the exact mechanism of MIRI and the role of the Epidermal growth factor receptor (EGFR)/Rho family GTPase 3 (RND3)/5' AMP-activated protein kinase (AMPK) pathway in MIRI-induced ferroptosis and mitochondrial dysfunction. The in vivo and in vitro I/R injury models were performed. Our results indicated that EGFR inhibition could effectively attenuate MIRI through inhibiting ferroptosis, as showed by elevated cell viability, increased LDH activity and apoptosis, prevented iron overload and abnormal lipid metabolism, maintained cardiac and mitochondrial function, reduced infarct size, decreased reactive oxygen species (ROS) and TUNEL-positive cells. Importantly, EGFR inhibition could upregulated the protein level of RND3, which could directly interact with AMPK and cause the phosphorylation and activation of it, then attenuating ferroptosis and mitochondrial dysfunction induced by MIRI. Finally, the effects of EGFR inhibition were abolished after pretreatment with pAd/RND3-shRNA or Compound C (an AMPK inhibitor). According to these findings, we conclude that the EGFR/RND3/AMPK axis plays a key role in the pathological process of MIRI and that EGFR inhibition could attenuate ferroptosis and mitochondrial dysfunction triggered by MIRI via activating the RND3/AMPK pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China; Department of Cardiovascular Surgery, The Second Affiliated Hospital,…
- Institute of Nanchang University Trauma Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
- Department of Cardiovascular Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China. Electronic address: ndyfy04759@ncu.edu.cn.
- Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China. Electronic address: ndyfy03743@ncu.edu.cn.
Förderung
- Natural Science Foundation of Jiangxi Province
- National Natural Science Foundation of China
Zitieren
APA
Hu, T., Wang, X. Q., Zou, C. C., Hu, F. J., Zhang, Z. Y., Qiao, Y. M., Liu, L. X., Liu, J. C., Huang, H., & Lai, S. Q. (2027). Epidermal growth factor receptor inhibition alleviates cardiac ischemia/reperfusion injury through preventing mitochondrial dysfunction and ferroptosis via Rho Family GTPase 3/5′ AMP-activated protein kinase axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2026.168501
Vancouver
Hu T, Wang XQ, Zou CC, Hu FJ, Zhang ZY, Qiao YM, et al. Epidermal growth factor receptor inhibition alleviates cardiac ischemia/reperfusion injury through preventing mitochondrial dysfunction and ferroptosis via Rho Family GTPase 3/5′ AMP-activated protein kinase axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2027. doi:10.1016/j.bbadis.2026.168501
BibTeX
@article{Hu2027,
author = {Hu, Tie and Wang, Xiu-Qi and Zou, Chen-Chao and Hu, Fa-Jia and Zhang, Ze-Yu and Qiao, Ya-Mei and Liu, Lan-Xiang and Liu, Ji-Chun and Huang, Huang and Lai, Song-Qing},
title = {Epidermal growth factor receptor inhibition alleviates cardiac ischemia/reperfusion injury through preventing mitochondrial dysfunction and ferroptosis via Rho Family GTPase 3/5′ AMP-activated protein kinase axis},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2027},
doi = {10.1016/j.bbadis.2026.168501}
}
EUVIMED